Table 3.
Patients with peak hs-TnT elevations
| Protective strategy | Dexrazoxane | Continuous infusion | Crossover |
|---|---|---|---|
| Patient Number | 8 | 11 | 10 |
| Peak hS-TnT > 5 ng/ml | 0 | 0 | 7 |
| Peak hs-TnT > 10 ng/ml | 6 | 3 | 1 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.